Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Myotonic Dystrophy Type 1 (DM1) or Type 2 (DM2) through genetic testing and/or clinical features, including those who have tested positive but have no symptoms, or those with characteristic features who have not had genetic testing done.
- People with no known muscular dystrophy who may be eligible to participate as a comparison (control) group.
- People who are able to give written consent or assent to take part in the study.
- For a single fluid sample collection: males and females aged 5 years and older.
- For repeated fluid samples and muscle function testing: males and females aged 14 years and older with DM1.
- For fluid samples and a muscle biopsy: males and females aged 18 to 65 years.
- For a single fluid sample collection combined with ultrasound and muscle response testing: males and females aged 14 years and older.
Who may not be able to join:
- People with a medical history of a weakened immune system, a blood clotting disorder, pre-existing liver or kidney disease, a documented positive HIV diagnosis, or documented hepatitis B and/or C.
- People who have taken anti-platelet medications (blood-thinning drugs that affect platelets) within the 7 days before a blood draw or biopsy.
- People who have taken anticoagulant medications (blood-thinning drugs) within the 60 days before a blood draw or biopsy.
- People with active drug or alcohol use or dependence that, in the opinion of the biopsy surgeon, could interfere with care after a biopsy procedure.
- People who are unwilling or unable to provide written informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thurman M. Wheeler, MD, Massachusetts General Hospital
Phone: 617-726-7506
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Extracellular RNA in biofluids
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.